Rdeb clinical trials

Explore recruiting rdeb clinical trials.

Recruiting rdeb studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Rdeb trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II, Open Study to Assess Efficacy and Safety of Rigosertib in Patients with Recessive Dystrophic Epidermolysis bullosa associated Locally Advanced/Metastatic Squamous Cell Carcinoma

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

A double-blind, randomized, placebo-controlled, interventional, multicenter, phase III clinical trial to investigate the safety and efficacy of ABCB5-positive mesenchymal stromal cells (ABCB5+ MSCs) on epidermolysis bullosa (EB)

Austria, Hungary, Poland, Italy, Germany, Denmark +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase I/II ex vivo gene therapy clinical trial for RDEB using autologous skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector

France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Rdeb trials by city

Rdeb in Toronto Rdeb in Vancouver Rdeb in Montreal Rdeb in Calgary Rdeb in Edmonton Rdeb in Ottawa Rdeb in Winnipeg Rdeb in Quebec City Rdeb in Hamilton Rdeb in Kitchener Rdeb in London Rdeb in Halifax Rdeb in New York Rdeb in Los Angeles Rdeb in Chicago Rdeb in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease